All terms
Trial Master File
The collection of essential documents that demonstrates the conduct of a clinical trial complies with GCP and applicable regulatory requirements.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 9, 2026
Definition
The Trial Master File (TMF) is the structured collection of essential documents — protocol, investigator brochure, regulatory approvals, informed consent forms, monitoring reports, IRB/EC correspondence, drug/device accountability, deviation logs, audit reports — that allows an inspector to reconstruct the conduct of the trial and assess GCP compliance. ICH E6(R3) defines the essential-documents list. Most modern trials use an electronic TMF (eTMF) aligned to the DIA TMF Reference Model. What the regulation says
ICH E6(R3) Good Clinical Practice. EU Regulation (EU) 536/2014 (Clinical Trials Regulation). FDA inspectors apply 21 CFR 312/812 essential-document expectations.
What this means in practice
TMF inspection-readiness is a perennial weak spot in BIMO inspections. Regulators expect the TMF to be contemporaneous, complete, and reconstructable in real time, not assembled retroactively before an inspection. Common pitfalls
- •Treating TMF assembly as a closeout activity rather than a continuous trial-conduct discipline.
- •Relying on an eTMF system without governance — system features alone do not produce inspection readiness.
Primary references
3 sourcesLink health: 3 verified· last checked 2026-05-09
DIA·1ICH·1NIH·1
- 1
DIA TMF Reference ModelVerifiedDIAtmfrefmodel.com
- 2
ICH E6(R3) GCPVerifiedICHich.org
- 3
ClinicalTrials.govVerifiedNIHclinicaltrials.gov
Inline markers like [1] jump to the matching reference above.